Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut Inflammation and/or Tightened Gut Mucosal Barrier |
|||||||
| 申请号 | US15772289 | 申请日 | 2016-09-08 | 公开(公告)号 | US20180312851A1 | 公开(公告)日 | 2018-11-01 |
| 申请人 | SYNLOGIC OPERATING COMPANY, INC.; | 发明人 | Dean Falb; Vincent M. Isabella; Jonathan W. Kotula; Paul F. Miller; Yves Millet; Adam Fisher; | ||||
| 摘要 | Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of treating or preventing autoimmune disorders, inhibiting inflammatory mechanisms in the gut, and/or tightening gut mucosal barrier function are disclosed. | ||||||
| 权利要求 | |||||||
| 说明书全文 | |||||||
QQ群二维码
意见反馈
意见反馈